VYST (Vystar) 1-Year Sharpe Ratio : 1.60 (As of Jul. 04, 2025)

View and export this data going back to 2009. Start your Free Trial

What is Vystar 1-Year Sharpe Ratio?

The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2025-07-04), Vystar's 1-Year Sharpe Ratio is 1.60.

Competitive Comparison of Vystar's 1-Year Sharpe Ratio

For the Specialty Chemicals subindustry, Vystar's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vystar's 1-Year Sharpe Ratio Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Vystar's 1-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where Vystar's 1-Year Sharpe Ratio falls into.

Save Embed

;

Save Embed

;

Vystar 1-Year Sharpe Ratio Calculation

The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.

Vystar (OTCPK:VYST) 1-Year Sharpe Ratio Explanation

The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.

Vystar 1-Year Sharpe Ratio Related Terms

Thank you for viewing the detailed overview of Vystar's 1-Year Sharpe Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Vystar Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Vystar Corp (OTCPK:VYST) » Definitions » 1-Year Sharpe Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

365 Shrewsbury Street, Worcester, MA, USA, 01604

Website

https://www.vytex.com

Vystar Corp is engaged in the rubber and plastic products market. It develops technology to produce Vytex Natural Rubber Latex which reduces antigenic protein and non-rubbers in natural rubber latex to undetectable levels. The company's products and services include Natural Rubber Latex and clinical sleep diagnostics and durable medical equipment. The company derives revenue from sales of or license fees of Vytex NRL raw material to manufacturers and distributors of rubber and rubber end products.

Executives

Byron Lee Novosad	other: Board Member	14019 SW FREEWAY, # 301 PMB 181, SUGAR LAND TX 77478
Bryan Lawrence Stone	director	C/O VYSTAR CORPORATION, 101 AYLESBURY RD., WORCESTER MA 01609
Keith D. Osborn	10 percent owner	5671 PEACHTREE-DUNWOODY RD., ATLANTA GA 30342
Paul R. Oristaglio	director	955 COUNTY ROAD, BARRINGTON RI 02806
Steven Rotman	director, officer: Chief Executive Officer	C/O VYSTAR CORPORATION, 101 AYLESBURY RD., WORCESTER MA 01609
Joseph Carmen Allegra	director	C/O VYSTAR CORPORATION, 101 AYLESBURY RD., WORCESTER MA 01609
William R. Doyle	director, officer: Chairman, President & CEO	VYSTAR CORPORATION, 3235 SATELLITE BLVD, BUILDING 400, SUITE 290, DULUTH GA 30096
Joseph Allegra	director	VYSTAR CORPORATION, 3235 SATELLITE BLVD., BUILDING 400, SUITE 290, DULUTH GA 30096
Jason M. Meggs	director	C/O SYNEOS HEALTH, INC., 1030 SYNC STREET, MORRISVILLE NC 27560
Ranjit K. Matthan	director	C/O VYSTAR CORPORATION, 2484 BRIARCLIFF RD NE, SUITE 159, ATLANTA GA 30329
Mangum Michelle (mitsy) Y.	director	VYSTAR CORPORATION, 3235 SATELLITE BLVD, BUILDING 400, SUITE 290, DULUTH GA 30096
Michael X Ianacone	director	C/O VYSTAR CORPORATION, 2484 BRIARCLIFF RD NE, SUITE 159, ATLANTA GA 30329
Thomas L Mills	director	C/O WINSTON & STRAWN,, 1400 L. STREET, N.W, WASHINGTON DC 20005
Paul A. Yeoham	director	C/O VYSTAR CORP., 3235 SATELLITE BLVD., BUILDING 400, SUITE 290, DULUTH GA 30096
Dale Thomas Marsh	director	C/O VYSTAR CORPORATION, 3235 SATELLITE BLVD., BLDG. 400, STE 290, DULUTH GA 30096